【英語タイトル】Non-PVC IV Bags Market By Product Type (Single Chamber, Multi Chamber), By Material Type (Polypropylene IV Bag, Polyethylene IV Bag, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
	・商品コード：ALD23MY035 ・発行会社（調査会社）：Allied Market Research ・発行日：2023年2月    最新版(2025年又は2026年)はお問い合わせください。 ・ページ数：250 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後24時間以内） ・調査対象地域：グローバル ・産業分野：医療機器

The Non-PVC IV bags market valued for $880.21 million in 2021 and is estimated to reach $1,684.50 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031.
Non-PVC IV bags are intravenous bags made up of non-polyvinyl chloride film. Non-PVC IV bags help reduce the risks associated with conventional IV bags, such as transportation issues and drug interactions with packaging and disposable containers. There is a rise in demand for non-PVC IV bags, which causes shift in the company’s focus on manufacturing PVC-free bags due to the benefits provided by PVC-free IV bags. This is expected to propel the market growth. These bags are quite popular in oncology therapy due to the associated benefits such as less pollution, safety, compatibility, lightweight, convenience to use, and low risk of contamination.
The growth of the global non-PVC IV bags market is majorly driven by increase in demand for non-PVC IV bags, owing to increase in number of cardiac surgical procedures increases the demand for non-PVC IV bags for transporting the fluids. For instance, according to the World Health Organization (WHO), nearly 90% of Chronic Obstructive Pulmonary Disease (COPD) deaths under 70 years of aged occur in low- and middle-income countries (LMIC). Thus, increase in cardiac surgical procedures has led to increase in the demand for non-PVC IV bags, as these bags are providing intravenous fluids to cardiac patients and receiving treatment for acute exacerbations.
In addition, increase in cases of Hospital Acquired Infections (HAI), due to lack of sanitation is the factor responsible for the market growth. For instance, Centers for Disease Control (CDC), estimated that around 1.7 million hospital acquired infections and 99,000 associated deaths each year occurred in the U.S. Thus, rise in cases of Hospital Acquired Infections (HAI) require intravenous antibiotics for weeks thereby increasing the demand for non-PVC IV bags.
Furthermore, increase in awareness regarding non-PVC IV bags in developed countries such as the U.S. and rise in improved designs of non-PVC IV bags further fuel the market growth. However, high cost of non-PVC IV bags and inadequate training to hospital staff about disposal of non-PVC IV bags hinders the market growth. Conversely, increase in demand for non-PVC IV bags and rise in advanced features in non-PVC IV bags are anticipated to provide lucrative opportunities to the market players.
The non-PVC IV bags market is segmented into product type, material type, end user, and region. By product type, the market is categorized into single chamber and multi chamber. By material type, the market is segregated into polypropylene IV bags, polyethylene IV bag, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global non-PVC IV bags market are B. Braun SE, BAUSCH Advanced Technology Group, Fagron Sterile Services US, Fresenius SE & Co. KGaA, ICU Medical, Inc., JW Holdings, KRATON CORPORATION, MEDI PHARMA PLAN Co.,Ltd. Sippex IV bags, and Technoflex.
Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non-pvc iv bags market analysis from 2021 to 2031 to identify the prevailing non-pvc iv bags market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the non-pvc iv bags market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global non-pvc iv bags market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
● Single Chamber
● Multi Chamber
By Material Type
● Polypropylene IV Bag
● Polyethylene IV Bag
● Others
By End User
● Hospitals
● Ambulatory Surgical Centers
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ Australia
○ India
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ ICU Medical, Inc.
○ JW Holdings
○ B. Braun SE
○ KRATON CORPORATION
○ Sippex IV bags
○ Fresenius SE and Co. KGaA
○ BAUSCH Advanced Technology Group
○ Fagron Sterile Services US
○ Technoflex
○ MEDI PHARMA PLAN Co.,Ltd.